Antibiotic Type Poses Severe Nerve Damage Risk, FDA Says

Law360, New York (August 15, 2013, 6:03 PM EDT) -- The U.S. Food and Drug Administration on Thursday warned that severe nerve damage can result from drugs in a popular class of antibiotics, including those produced by Bayer AG and Johnson & Johnson, expanding a previous alert that regulators said was too vague about potential harm.

In its announcement, the FDA said it would require label updates for all fluoroquinolone antibacterial drugs, including Bayer’s Cipro and J&J’s Levaquin, after finding that earlier cautions about the risk of peripheral neuropathy failed to fully inform doctors and patients...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.